The Infant Immune System Implications for Vaccines and Response to Infections (R01) | Apply Online

Opportunity Summary:

The Infant Immune System: Implications for Vaccines and Response to Infections (R01) is a discretionary NIH grant opportunity from the National Institute of Allergy and Infectious Diseases (NIAID) focused on understanding how immunity is established and maintained during infancy, specifically in babies from birth through 12 months of age. The core scientific purpose is to define the mechanisms that shape immune protection after either natural infection or vaccination against infectious agents that commonly cause illness in this highly vulnerable age group. By targeting the first year of life, the program aims to fill major knowledge gaps about why infant immune responses can differ from those of older children and adults, and how those early-life responses can be guided to produce stronger, longer-lasting protection.

A central theme of the announcement is improving long-term immune status by clarifying infant immune defense mechanisms. In practical terms, the research supported under this funding opportunity is meant to generate insights that could lead to better vaccine strategies, better timing or formulation of immunizations, and improved approaches for preventing or managing early childhood infections. The scope is not limited to vaccines alone; it also covers immunity that develops after infection, with the overarching intent of learning how protective immune memory and durable immune function can be built in the earliest stages of life.

To promote creative and high-impact ideas, NIAID explicitly notes that extensive preliminary data is not required, and applicants do not need a long track record specifically in neonatal immunology to be competitive. This lowers a common barrier to entry and is designed to attract innovative teams, including investigators who may bring new methods, models, or conceptual approaches from adjacent fields such as systems immunology, vaccinology, mucosal immunology, microbiology, or pediatric infectious diseases. The announcement also encourages research using human cells and tissues, reflecting the value of directly studying human infant immunology where feasible and ethical, while still allowing the use of infant animal models when they are well-justified and appropriate to the scientific question.

Mechanistically oriented studies are the clear priority. Projects would be expected to move beyond descriptive observations and instead explain how infant immune responses are generated, regulated, and sustained. That can include understanding how infants develop immune memory, how innate and adaptive immune components interact early in life, what factors influence vaccine responsiveness, and what drives protective versus suboptimal outcomes after exposure to pathogens. The diseases of interest are infectious diseases affecting infants, with emphasis on agents responsible for common or serious childhood infections.

Administratively, this is an R01 research project grant, meaning it supports investigator-initiated, hypothesis-driven or discovery-driven research programs that typically require a multi-year plan and a coherent set of aims. The opportunity is identified as Funding Opportunity Number RFA-AI-11-010, posted March 11, 2011, with an original and current closing date of July 8, 2011, and an archive date of August 8, 2011. The estimated total funding available is $2.3 million, with an award ceiling of $300,000. There is no cost sharing or matching requirement, which reduces financial burden on applicants and partnering organizations.

Eligibility is broad and inclusive, encompassing public and private institutions of higher education, nonprofits (including both 501(c)(3) and non-501(c)(3) entities), for-profit organizations (including small businesses), independent school districts, and a wide range of government entities (state, county, city/township, special district). Eligibility also extends to Tribal governments and Tribal organizations, public housing authorities/Indian housing authorities, and a variety of mission-focused institutions such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribal Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and faith-based or community-based organizations. Importantly, the program allows participation by non-U.S. entities (foreign organizations), regional organizations, U.S. territories or possessions, and foreign components of U.S. organizations, which signals openness to globally relevant infant immunology research and international collaboration where appropriate.

The program falls under NIH CFDA numbers 93.855 (Allergy, Immunology and Transplantation Research) and 93.856 (Microbiology and Infectious Diseases Research), reflecting its intersection between fundamental immune mechanisms and infectious disease outcomes. Applicants are directed to the full announcement via the NIH Grants Guide link provided in the notice, and technical access issues are routed through the NIH Office of Extramural Research webmaster contacts listed.

Overall, this opportunity is best understood as a targeted investment by NIAID in decoding early-life immunity so that vaccines and other preventive strategies can be better aligned with how infant immune systems actually work. The solicitation emphasizes mechanistic insight, encourages use of human biological materials when possible, accepts justified infant animal models, and explicitly invites innovative entrants by not requiring heavy preliminary data or long-standing neonatal immunology credentials.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Development and Translation of Medical Technologies to Reduce Health Disparities (R43/R44)

Previous opportunity: Research Centers for Excellence in Clinical Preventive Services (P01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AI 11 010

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AI 11 010) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AI 11 010", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.